Please ensure Javascript is enabled for purposes of website accessibility

NFL Owners Soften Their Stance on Marijuana Use in Latest Collective Bargaining Proposal

By David Jagielski – Feb 24, 2020 at 2:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The league is no longer looking to suspend players who use cannabis.

The National Football League is starting to come around on its marijuana policy. The collective bargaining agreement between the league and its players runs out at the end of next season, and the two sides are in negotiations for a new one. Among the items in the proposal that NFL owners recently submitted to players was a plan to reduce the penalties for marijuana use, and change the way that the league it tests for it.

One of the biggest changes is that the league would no longer suspend players who test positive for cannabis. In addition, the league would test fewer players, and the testing window would shrink from a period of four months to just two weeks.

Dallas Cowboys' owner Jerry Jones has hinted in the past that there will likely be an "adjustment" in the way the league handles its drug policy with respect to marijuana use.

Cannabis plant.

Image source: Getty Images.

Other sports leagues already further ahead

The NFL has been one of the harshest professional sports leagues when it comes to how it responds to players using marijuana. Canopy Growth (CGC 4.89%) has partnered with the National Hockey League (NHL) Alumni Association to research how cannabis can help former players dealing with injuries related to their athletic careers. Canopy Growth is active in the sports industry, and in October, it announced that it bought a majority stake in sports drink company Biosteel. The company intends to develop hemp-based cannabidiol (CBD) products designed for athletes.

Rival marijuana producer Aurora Cannabis (ACB 6.85%) partnered with the Ultimate Fighting Championship (UFC) in 2019 to do research on the impact that hemp-based CBD products can have on athletes in terms of improving their overall wellness and recovery times from injuries.

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
$3.00 (4.89%) $0.14
Aurora Cannabis Stock Quote
Aurora Cannabis
$1.29 (6.85%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.